| Filing Date | T Date | Ticker | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/9/04 16:34 | 12/7/04 | EBIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Whitmore Bradford T | IL | T | S | -155 | 2.91 | 0 | -53 | -1 | 5,575 | I | |||||||||||||||
| 12/9/04 16:34 | 12/7/04 | EBIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Grace Brothers Ltd | IL | T | S | -155 | 2.91 | 0 | -53 | -1 | 4,473 | D | |||||||||||||||
| 12/6/04 20:01 | 12/3/04 | EBIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Grace Brothers Ltd | IL | T | S.m | -740 | 2.94 | 0 | -251 | -5 | 4,527 | D | |||||||||||||||
| 12/6/04 19:44 | 12/6/04 | EBIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Whitmore Bradford T | IL | T | S | -439 | 2.98 | 0 | -148 | -3 | 5,629 | I | |||||||||||||||
| 12/6/04 19:09 | 12/2/04 | EBIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Whitmore Bradford T | IL | T | S.m | -665 | 2.92 | 0 | -227 | -2 | 11,675 | M | |||||||||||||||
| 8/8/03 17:47 | 8/8/03 | EBIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Gerber William G | WA | DO | CEO | P | 9 | 2.25 | 0 | 4 | 67 | 10 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |